GreyLion Partners and Denali Growth Partners completed the investment in Slipstream.

GreyLion Partners and Denali Growth Partners, a private equity firms, completed the investment in Slipstream, a technology partner serving the pharmaceutical and biopharmaceutical industry. Financial terms were not disclosed. “The dynamic pharmaceutical regulatory environment requires a need for compliant capabilities with specific expertise around the industry, and our suite of services is catered to support these unique requirements and complexities. We believe there are significant opportunities to further scale our platform. Our team is thrilled to partner with GreyLion and DGP. We look forward to leveraging their long-standing experience and expertise to help us achieve our strategic business objectives,” Brandon McKay, Slipstream CEO and Founder.